Full name
PROLAB SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
72.19.Z - Other research and experimental development on natural sciences and engineering
10.86.Z - Manufacture of homogenised food preparations and dietetic food
21.20.Z - Manufacture of medicines and other pharmaceutical products
32.99.Z - Other manufacturing notelsewhere classified
46.90.Z - Non-specialised wholesale trade
47.19.Z - Other retail sale in non-specialised stores
72.11.Z - Research and experimental development on biotechnology
85.59.B - Other out-of-school forms of education, not elsewhere classified
86.90.E - Other human health activities notelsewhere classified
96.09.Z - Other personal service activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,1 | 0,1 | -0 | -173 |
EBITDA | 0,1 | 0,1 | -0 | -126,2 |
Short time liabilities | 0,1 | 0,1 | 0,1 | 45,3 |
Equity capital | 0,4 | 0,5 | 0,3 | -32,2 |
Operating profit (EBIT) | 0,1 | 0,1 | -0,1 | -177,6 |
Assets | 0,5 | 0,5 | 0,4 | -22,8 |
Net profit (loss) | 0,1 | 0,1 | -0 | -188,6 |
Cash | 0,2 | 0,1 | 0,1 | -16,9 |
Net income from sale | 1 | 1,2 | 1,5 | 22,5 |
Liabilities and provisions for liabilities | 0,1 | 0,1 | 0,1 | 45,3 |
Working assets | 0,4 | 0,5 | 0,4 | -20,8 |
Depreciation | 0 | 0 | 0 | -43,1 |
% | % | % | p.p. | |
Profitability of capital | 20,2 | 12,1 | -15,8 | -27,9 |
Equity capital to total assets | 88 | 87,8 | 77,1 | -10,7 |
Gross profit margin | 8,7 | 5,4 | -3,2 | -8,6 |
EBITDA Margin | 12,7 | 8,7 | -1,9 | -10,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 22 | 19 | 22 | 3 |
Current financial liquidity indicator | 7.089662075042725 | 7.598043918609619 | 4.141213893890381 | -3,5 |
Net dept to EBITDA | -1.6004517078399658 | -1.2043180465698242 | 4.181534767150879 | 5,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane